lovastatin has been researched along with Hyperlipoproteinemias in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 15 (88.24) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jingami, H | 1 |
| Johansson, J; Lithell, H; Ohrvall, M; Vessby, B | 1 |
| Albers, JJ; Bisson, B; Brown, BG; Fisher, L; Hillger, L; Sacco, D; Zhao, XQ | 1 |
| Hosomi, N; Izumi, Y; Kitadai, M; Satoh, K; Takahashi, T; Tsuda, Y | 1 |
| Ikegami, T; Kano, M; Matsuzaki, Y; Miyamoto, J; Miyazaki, H; Osuga, T; Shoda, J; Tanaka, N | 1 |
| Barter, P; Clifton, P; Colquhoun, D; Hamilton-Craig, I; Nestel, P; Sikaris, K; Simons, L; Sullivan, D | 1 |
| Kesten, S; Maurer, J; Mayne, L; Scavuzzo, M | 1 |
| Idzior-WaluĊ, B | 1 |
| Eichinger, M; Feussner, G; Ziegler, R | 1 |
| Glueck, CJ; Lang, J; Oakes, N; Speirs, J; Tracy, T | 1 |
| Ditschuneit, HH; Ernst, E; Hehr, R; Hombach, V; Koenig, W; Kuhn, K; Rosenthal, J | 1 |
| Hockwin, O; Schmidt, J; Schmitt, C | 1 |
| Ansuini, R; Barone, A; Francolini, G; Frausini, G; Pupita, F | 1 |
| Bochkova, EI; Iurenev, AP; Kotkina, AA; Lediashova, GA; Martynov, AA; Pomerantsev, EV; Shabalkin, BV; Shimbaeva, NA; Titov, VN; Zhukova, IM | 1 |
| Bilodeau, M; Cianflone, K; Davignon, J; Sniderman, AD | 1 |
| Iurenev, AP; Kiseleva, OA; Lediashova, GA; Pomerantsev, EV; Zhukova, IM | 1 |
2 review(s) available for lovastatin and Hyperlipoproteinemias
| Article | Year |
|---|---|
Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis.
Topics: Cholesterol; Clofibrate; Coronary Disease; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Lactation; Lipoproteins; Lovastatin; Naphthalenes; Niacin; Pentanoic Acids; Pregnancy; Pregnancy Complications; Probucol; Tangier Disease; Triglycerides | 1984 |
[HMG-CoA reductase inhibitor for therapy of patients with hyperlipoproteinemia ].
Topics: Animals; Cholesterol; Cholesterol, LDL; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Lovastatin; Receptors, LDL | 1994 |
6 trial(s) available for lovastatin and Hyperlipoproteinemias
| Article | Year |
|---|---|
A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemia.
Topics: Aged; Body Weight; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Gemfibrozil; Glucose Tolerance Test; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Insulin; Lipoprotein Lipase; Lipoprotein(a); Lipoproteins, LDL; Lipoproteins, VLDL; Lovastatin; Male; Middle Aged; Simvastatin | 1995 |
Effects of intensive lipid-lowering therapy on the coronary arteries of asymptomatic subjects with elevated apolipoprotein B.
Topics: Adult; Apolipoproteins B; Colestipol; Coronary Disease; Coronary Vessels; Double-Blind Method; Exercise Test; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Niacin; Radiography | 1993 |
Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.
Topics: Acyl Coenzyme A; Blood Viscosity; Cholesterol; Enzyme Inhibitors; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hyperlipoproteinemias; Lovastatin; Male; Middle Aged; Pravastatin; Simvastatin; Triglycerides | 1996 |
A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin.
Topics: Anticholesteremic Agents; Apolipoproteins E; Cholesterol; Cross-Over Studies; Dietary Fats; Gemfibrozil; Genotype; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemias; Hypolipidemic Agents; Insulin; Lipids; Lipoprotein(a); Lipoproteins; Lovastatin; Predictive Value of Tests; Simvastatin; Triglycerides | 1997 |
The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia.
Topics: Adult; Apolipoprotein E2; Apolipoproteins E; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Dietary Fats; Double-Blind Method; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemias; Lipids; Lipoproteins; Lipoproteins, VLDL; Lovastatin; Male; Simvastatin; Triglycerides | 1992 |
Lovastatin alters blood rheology in primary hyperlipoproteinemia: dependence on lipoprotein(a)?
Topics: Bezafibrate; Blood Viscosity; Delayed-Action Preparations; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Rheology; Single-Blind Method | 1992 |
9 other study(ies) available for lovastatin and Hyperlipoproteinemias
| Article | Year |
|---|---|
Simultaneous determination of plasma mevalonate and 7alpha-hydroxy-4-cholesten-3-one levels in hyperlipoproteinemia: convenient indices for estimating hepatic defects of cholesterol and bile acid syntheses and biliary cholesterol supersaturation.
Topics: Adult; Aged; Bile; Bile Acids and Salts; Cholestenones; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemias; Intestinal Absorption; Liver; Lovastatin; Male; Mevalonic Acid; Middle Aged; RNA, Messenger; Simvastatin | 1997 |
Lack of left ventricular dysfunction associated with sustained exposure to hyperlipidemia following lung transplantation.
Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Echocardiography; Female; Follow-Up Studies; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Immunosuppressive Agents; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Lovastatin; Lung Transplantation; Male; Middle Aged; Myocardial Ischemia; Probucol; Radionuclide Angiography; Retrospective Studies; Triglycerides; Ventricular Dysfunction, Left; Ventricular Function, Left | 1997 |
[Influence of lovastatin on serum lipids in patients with primary hyperlipidemia phenotype IIa and IIb. I. Efficacy of lovastatin in the treatment of hyperlipoproteinemia].
Topics: Adolescent; Adult; Aged; Humans; Hyperlipidemias; Hyperlipoproteinemias; Lipids; Lovastatin; Male; Middle Aged; Phenotype | 1992 |
Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemias.
Topics: Adult; Aged; Analysis of Variance; Cholesterol; Combined Modality Therapy; Creatine Kinase; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipoproteinemias; Liver Function Tests; Lovastatin; Male; Middle Aged; Myositis; Retrospective Studies; Triglycerides | 1992 |
[The HMG-CoA reductase inhibitors simvastatin and pravastatin. No indication for side effects in use on humans].
Topics: Adult; Cataract; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Lovastatin; Middle Aged; Pravastatin; Refraction, Ocular; Risk Factors; Simvastatin; Visual Acuity | 1991 |
[The treatment of refractory hyperlipoproteinemias].
Topics: Anticholesteremic Agents; Cholesterol; DEAE-Dextran; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemias; Lovastatin; Male; Middle Aged; Simvastatin; Triglycerides | 1990 |
[The effect of lovastatin therapy on the dynamics of the clinical state of patients with ischemic heart disease and hyperlipoproteinemia].
Topics: Adult; Apolipoproteins; Cholesterol; Coronary Artery Disease; Coronary Disease; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Hyperlipoproteinemias; Lipoproteins; Lovastatin; Male; Middle Aged; Triglycerides | 1990 |
Modulation of chylomicron remnant metabolism by an hepatic hydroxymethylglutaryl coenzyme A reductase inhibitor.
Topics: Apolipoproteins B; Cholesterol; Chylomicrons; Dietary Fats; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Lipoproteins, LDL; Liver; Lovastatin; Male; Middle Aged; Oleic Acid; Oleic Acids; Time Factors; Triglycerides; Vitamin A | 1990 |
[The effectiveness of the hypolipemic preparation lovastatin in patients with ischemic heart disease and hyperlipoproteinemia].
Topics: Adult; Chronic Disease; Coronary Artery Disease; Coronary Disease; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Hyperlipoproteinemias; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged | 1989 |